Biocryst Pharmaceuticals (BCRX) Cash & Current Investments (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) reported Cash & Current Investments of $352.57 million for Q2 2026, up 35.6% from $260.04 million a year earlier and up 47.9% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Biocryst Pharmaceuticals posted Cash & Current Investments of $274.75 million, down 14.4% from FY2024.
- Cash & Current Investments has declined for four consecutive years, with a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $320.85 million in FY2024 (-17.5%), $388.99 million in FY2023 (-8.3%), $424.31 million in FY2022 (-16.4%) and $507.6 million in FY2021 (+69.0%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Current Investments since Q4 2023.
- Year over year, Cash & Current Investments gained in 1 of the last eight quarters, with an average decline of 10.6%.
- The high point for year-over-year Cash & Current Investments in five years was Q3 2022 (growth of 113.9%); the low point was Q3 2025 (a decline of 35.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $238.4 million (Q1 2026), $274.75 million (Q4 2025) and $212.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Biocryst Pharmaceuticals | 2.09 Bn | 1.01 Bn | 214.41 Mn | 352.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 352.57 Mn |
| Mar 31, 2026 | 238.40 Mn |
| Dec 31, 2025 | 274.75 Mn |
| Sep 30, 2025 | 212.87 Mn |
| Jun 30, 2025 | 260.04 Mn |
| Mar 31, 2025 | 295.09 Mn |
| Dec 31, 2024 | 320.85 Mn |
| Sep 30, 2024 | 330.01 Mn |
| Jun 30, 2024 | 272.03 Mn |
| Mar 31, 2024 | 336.55 Mn |
| Dec 31, 2023 | 388.99 Mn |
| Sep 30, 2023 | 397.59 Mn |
| Jun 30, 2023 | 410.67 Mn |
| Mar 31, 2023 | 398.16 Mn |
| Dec 31, 2022 | 424.31 Mn |
| Sep 30, 2022 | 426.86 Mn |
| Jun 30, 2022 | 417.48 Mn |
| Mar 31, 2022 | 443.47 Mn |
| Dec 31, 2021 | 507.60 Mn |
| Sep 30, 2021 | 199.60 Mn |
API Access
Biocryst Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();